Bio-Path Holdings (BPTH) said Thursday it closed a private placement of about 4.6 million shares, series A warrants, and short-term series B warrants at a purchase price of $0.87 per share of common stock.
The gross proceeds to the company were about $4 million, it said late Thursday.
Series A and short-term series B warrants are for purchasing up to about 6.41 million shares of common stock. Both warrants have an exercise price of $1 per share.
The company intends to use the net proceeds for working capital and general corporate purposes.
Price: 1.1300, Change: -0.01, Percent Change: -0.88
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments